According to a recent market study published by Growth Market Reports, titled, “Global Protein Sequencing Market By Products and Services, By Technology, By Application, By End-user and By Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 1,143.0 Million in 2022 and is anticipated to expand at a growth rate of 4.4% by 2031.

Protein sequencing is a foundational technique in molecular biology and biochemistry that involves determining the precise order of amino acids within a protein molecule. These amino acids are the building blocks of proteins and are arranged in a specific linear sequence, often referred to as the protein's primary structure. Understanding this primary structure is similar to deciphering the genetic code of proteins, and it holds immense significance across various scientific disciplines.

Get Sample Report @ https://growthmarketreports.com/request-sample/6153

The global Protein Sequencing market has been segmented in terms of Products and Services, Technology, Application, End-user, and region. In terms of Products and Services, the global Protein Sequencing market is split into instruments, reagents & consumables, and software & services. On the basis of Technology, the market is fragmented into sequencing-by-degradation, sequencing-by-transit, and sequencing-by-affinity. Based on Application, the market is divided into biomarker discovery, protein engineering studies, biotherapeutics, and others.  Based on end-user, the market is divided into academic institutes & research centers, pharmaceutical & biotechnology companies, contract research organizations, and others. Considering regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The COVID-19 pandemic had a considerable impact on various markets, including the Protein Sequencing market. The COVID-19 disease caused serious respiratory illnesses. Hence, accurate identification of the viral infection cycle plays a vital role in designing appropriate vaccines. The risk of this disease primarily depends on proteins that interact with human receptors.

Key Takeaways from the Study:

  • Players in the global Protein Sequencing market include Charles River Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation, Selvita SA, SGS SA, Bruker, Rapid Novor Inc, Bioinformatics Solutions, Proteome Factory, AltaBioscience Ltd, Creative Proteomics, and Quantum-Si, Inc. These players held a major share of the global Protein Sequencing market in 2022.

  • Increasing Research & Development Activities in Proteomics is key factors that drive the Protein Sequencing market.

  • Investment In Research Related to Genomic Studies and Proteomics is expected to create opportunities in the coming years.

  • Based on Products and Services, the market is segmented into instruments, reagents & consumables, and software & services. The software & services segment is expected to hold a considerable share of the market during the forecast period, as software is securely accessible from any computer, thus, supporting analysis from any location and facilitating collaboration with global partners in the analysis.

  • Based on Technology, the market is segmented into sequencing-by-degradation, sequencing-by-transit, and sequencing-by-affinity. The sequencing-by-affinity segment is anticipated to expand at a lucrative CAGR during the forecast period, as it is a vital technology that is used to identify and quantify DNA in mixtures, along with methods such as DNA microarray technologies.

  • Based on application, the market is segmented into biomarker discovery, protein engineering studies, biotherapeutics, and others. The biotherapeutic segment is anticipated to expand at a lucrative CAGR during the forecast period, as biotherapeutic molecules are considered a rapidly growing drug class for anti-immunity, inflammatory diseases, and oncology.

  • Based on the end-user, the market is segmented into academic institutes & research centers, pharmaceutical & biotechnology companies, contract research organizations, and others. The academic institutes & research centers segment is anticipated to expand at a significant CAGR during the forecast period, as these centers design studies to assess techniques for determining the primary structure of protein terminus that further allow participating laboratories to gauge their expectations & competence in performing the required analysis.

  • Based on regions, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.  Europe accounted for a significant share of the market in 2022, owing to the growing number of pharmaceutical and biotechnology companies in the region. According to the European Federation of Pharmaceutical Industries and Associations, the research-based pharmaceutical industry is a key asset of the European economy. moreover, it is one of the top-performing high-technology sectors in Europe.

  Report Scope:

Report Metric

Details

Market Value in 2022

US$ 1,143.0 Million

Market Growth Rate (from 2022 to 2031)

4.4%

Historical Data

2016 & 2021

Base Year

2022

Forecast Period

2023 – 2031

Units Considered

Value (US$ Million)

Market Segments

By Products and Services, By Technology, By Application, By End-user, and By Region

Key Companies Profiled

Charles River Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation, Selvita SA, SGS SA, Bruker, Rapid Novor Inc, Bioinformatics Solutions, Proteome Factory, AltaBioscience Ltd, Creative Proteomics, and Quantum-Si, Inc.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.


Target Audience:

  • Supply-side: Vendor, Manufacturer, Distributors, Supplier, Retailer.

  • Regulatory Side: Concerned government authorities, and other approved regulatory bodies.

  • Proteomics Centers Network (PCN)

  • Egyptian Knowledge Bank (EKB)

  • National Institutes of Health (NIH)